Nfe2l1-silenced insulinoma cells acquire aggressiveness and chemoresistance.
Fu J, Zheng H, Cui Q, Chen C, Bao S, Sun J, Li L, Yang B, Wang H, Hou Y, Xu Y, Xu Y, Zhang Q, Pi J.
Fu J, et al. Among authors: sun j.
Endocr Relat Cancer. 2018 Mar;25(3):185-200. doi: 10.1530/ERC-17-0458. Epub 2017 Dec 4.
Endocr Relat Cancer. 2018.
PMID: 29203613